Alivecor, Inc. v. Apple, Inc.

District Court, N.D. California·Decided October 18, 2022·No. 4:21-cv-03958·Unknown

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 ALIVECOR, INC., Case No. 21-cv-03958-JSW

8 Plaintiff, ORDER GRANTING MOTION FOR 9 v. LEAVE TO FILE FIRST AMENDED COMPLAINT AND DENYING 10 APPLE INC., MOTIONS TO SEAL Defendant. Re: Dkt. No. 84, 94, 98 11

12 13 Now before the Court for consideration is the motion for leave to file first amended 14 complaint (“FAC”) filed by Plaintiff AliveCor, Inc. (“AliveCor”). The Court has considered the 15 parties’ papers, relevant legal authority, and the record in the case, and it finds this matter suitable 16 for disposition without oral argument. See N.D. Civ. L.R. 7-1(b). For the following reasons, the 17 Court GRANTS AliveCor’s motion. 18 BACKGROUND 19 AliveCor filed this antitrust lawsuit against Defendant Apple Inc. (“Apple”) on May 25, 20 2021. (Dkt. No. 1.) AliveCor alleges that Apple monopolized the market for watchOS heart rate 21 analysis apps through a series of anticompetitive acts, including by changing the watchOS to 22 prevent competitors, like AliveCor, from offering their version of such apps to Apple Watch users. 23 On August 22, 2022, AliveCor filed the present motion seeking leave to supplement the 24 complaint to assert additional claims, factual allegations, and damages against Apple. AliveCor’s 25 proposed supplemental complaint alleges Apple has abused the inter parties review (“IPR”) 26 system at the federal Patent and Trademark Office by filing five IPRs for the sole purpose of 27 driving AliveCor out of business. (See Dkt. No. 84, Ex. 1 (“FAC”).) Specifically, AliveCor 1 including patents relating to another one of its products, the KardiaMobile Card. (Id. ¶¶ 96-98.) 2 AliveCor alleges that Apple instituted the IPRs solely to force AliveCor to expend resources 3 defending against those petitions rather than pursuing its antitrust claims. (Id. ¶ 98.) AliveCor 4 alleges the IPRs are motivated by anticompetitive intent and are causally linked to the earlier 5 anticompetitive acts related to watchOS and the heart rate algorithms. (Id. ¶ 105.) AliveCor 6 alleges it has suffered additional antitrust damages in the form of litigation expenses as a result of 7 Apple’s allegedly anticompetitive litigation scheme. (Id. ¶ 147.) 8 Apple filed an opposition to AliveCor’s motion. (Dkt. No. 91.) On September 13, 2022, 9 AliveCor filed its reply. (Dkt. No. 95.) AliveCor subsequently filed a notice of amended reply to 10 clarify certain statements in its reply brief in response to Apple’s request. (Dkt. No. 97.) 11 The Court will address additional facts as necessary in the analysis. 12 ANALYSIS 13 A. Applicable Legal Standard. 14 AliveCor seeks leave to file a supplemental pleading under Federal Rule of Civil 15 Procedure 15(d). Under Rule 15(d), “[o]n motion and reasonable notice, the court may, on just 16 terms, permit a party to serve a supplemental pleading setting out any transaction, occurrence, or 17 event that happened after the date of the pleading to be supplemented.” Fed. R. Civ. P. 15(d); see 18 also Eid v. Alaska Airlines, Inc., 621 F.3d 858, 874 (9th Cir. 2010) (“Rule 15(d) provides a 19 mechanism for parties to file additional causes of action based on facts that didn’t exist when the 20 original complaint was filed.”). “While leave to permit supplemental pleading is ‘favored,’ it 21 cannot be used to introduce a ‘separate, distinct and new cause of action.’” Planned Parenthood 22 of S. Ariz. v. Neely, 130 F.3d 400, 402 (9th Cir.1997) (citations omitted). Supplementation is 23 generally favored as “a tool of judicial economy and convenience.” Keith v. Volpe, 858 F.2d 467, 24 473 (9th Cir. 1988). “To determine if efficiency might be achieved, courts assess ‘whether the 25 entire controversy between the parties could be settled in one action.’” Id. (citation and ellipses 26 omitted). “The clear weight of authority ... in both the cases and the commentary, permits the 27 bringing of new claims in a supplemental complaint to promote the economical and speedy 1 supplemental complaint should have some relation to the claim set forth in the original pleading, 2 the fact that the supplemental pleading technically states a new cause of action should not be a bar 3 to its allowance, but only a factor to be considered by the court in the exercise of its discretion, 4 along with such factors as possible prejudice or laches.” Id.; see also Copeland v. Lane, 11-cv- 5 1058-EJD, 2013 WL 1899741, at *5 (N.D. Cal. May 6, 2013) (“Matters newly alleged in a 6 supplemental complaint must have some relation to the claims set forth in the original pleading.”). 7 “The legal standard for granting or denying a motion to supplement under Rule 15(d) is the 8 same as for amending one under 15(a).” Paralyzed Veterans of America v. McPherson, No. C 06- 9 4670 SBA, 2008 WL 4183981, at *26 (N.D. Cal. Sept. 9, 2008). The five factors commonly used 10 to evaluate the propriety of a motion for leave to amend (and thus, a motion to supplement) are: 11 (1) undue delay, (2) bad faith or dilatory motive on the part of the movant, (3) repeated failure of 12 previous amendments, (4) undue prejudice to the opposing party, and (5) futility of the 13 amendment. See Foman v. Davis, 371 U.S. 178, 182 (1962). “[T]he consideration of prejudice to 14 the opposing party…carries the greatest weight.” Eminence Capital, LLC v. Aspeon, Inc., 316 15 F.3d 1048, 1052 (9th Cir.2003). Absent prejudice or a “strong showing” of any other Foman 16 factor, there is a presumption in favor of granting leave to supplement. Id. 17 B. The Court Grants Leave to Supplement. 18 1. Bad Faith 19 Leave to amend may be denied if the amendment is introduced solely for delay or 20 improper purpose. Foman, 371 U.S. at 182. Here, AliveCor’s proposed supplement adds a new 21 theory of antitrust damage. The conduct underlying the proposed supplement allegedly began in 22 April 2022. Although Apple’s motion gestures at gamesmanship, Apple does not expressly 23 challenge AliveCor’s motion based on bad faith. Accordingly, the Court finds this factor favors 24 AliveCor. 25 2. Futility 26 A district court should give leave to amend “freely” but may deny leave to amend when 27 amendment would be futile. Fed. R. Civ. P. 15(a)(2); Sonoma Cty. Ass’n of Retired Emps. v. 1 can be proved under the amendment to the pleadings that would constitute a valid and sufficient 2 claim or defense.” Missouri ex rel. Koster v. Harris, 847 F.3d 646, 656 (9th Cir. 2017) (quoting 3 Miller v. Rykoff-Sexton, Inc., 845 F.2d 209, 214 (9th Cir. 1988)). “[C]ourts will determine the 4 legal sufficiency of a proposed amendment using the same standard as applied on a Rule 12(b)(6) 5 motion.” Miller, 845 F.2d at 214. However, “such issues are often more appropriately raised in a 6 motion to dismiss rather than in an opposition to a motion for leave to amend.” Stearns v. Select 7 Comfort Retail Corp., 763 F. Supp. 2d 1128, 1154-55 (N.D. Cal. 2010). 8 AliveCor argues that its proposed supplemental allegations are not futile under Hynix 9 Semiconductor Inc. v. Rambus, Inc.,

Alivecor, Inc. v. Apple, Inc., (N.D. Cal. 2022).

Alivecor, Inc. v. Apple, Inc. (Alivecor, Inc. v. Apple, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Nixon v. Warner Communications, Inc.
435 U.S. 589 (Supreme Court, 1978)
Pintos v. PACIFIC CREDITORS ASS'N
605 F.3d 665 (Ninth Circuit, 2010)
Eid v. Alaska Airlines, Inc.
621 F.3d 858 (Ninth Circuit, 2010)
Phillips v. General Motors Corporation
307 F.3d 1206 (Ninth Circuit, 2002)
Hynix Semiconductor Inc. v. Rambus, Inc.
527 F. Supp. 2d 1084 (N.D. California, 2007)
Stearns v. Select Comfort Retail Corp.
763 F. Supp. 2d 1128 (N.D. California, 2010)
State of Missouri v. Kamala Harris
847 F.3d 646 (Ninth Circuit, 2016)
Keith v. Volpe
858 F.2d 467 (Ninth Circuit, 1988)